People · Operator

Alex Bondar

Named in public records as an officer, director or promoter · active 2018–2025 · Agriculture, Other, Other Technology

3
Companies
6
Filings
$39.4M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Ascribe Bioscience Inc.AgricultureSeries B$22.9M$60.7M2021
Material Impact, Inc.OtherSeries A$13.8M$123.7M2021
ImpactVision, Inc.Other TechnologySeed$2.6M$45.7M2018
Operator network

Alex Bondar at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Frank Schroeder · 2 companies · 1 sharedFrank SchroederKyle Welborn · 2 companies · 1 sharedKyle WelbornFred Gruis · 1 companies · 1 sharedFred GruisJay Farmer · 1 companies · 1 sharedJay FarmerCRAIG SHAPIRO · 15 companies · 1 sharedCRAIG SHAPIROEmily Malina · 1 companies · 1 sharedEmily MalinaMartin Sirkin · 1 companies · 1 sharedMartin SirkinNiko Hrdy · 1 companies · 1 sharedNiko HrdyRichard Ashenfelter · 1 companies · 1 sharedRichard Ashenfelt…ABILASHA RAMANAN · 1 companies · 1 sharedABILASHA RAMANANGUSTAV NIPE · 1 companies · 1 sharedGUSTAV NIPERACHAEL GAN · 1 companies · 1 sharedRACHAEL GANVANN WALKE · 1 companies · 1 sharedVANN WALKEAscribe Bioscience Inc. · $22.9M raisedAscribe Bioscience In…Material Impact, Inc. · $13.8M raisedMaterial Impact, Inc.ImpactVision, Inc. · $2.6M raisedImpactVision, Inc.Alex BondarAB
Alex Bondar Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Alex Bondar on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
CRAIG SHAPIRO115
Kyle Welborn12
Frank Schroeder12
Emily Malina11
Richard Ashenfelter11
Niko Hrdy11
Martin Sirkin11
RACHAEL GAN11
ABILASHA RAMANAN11
GUSTAV NIPE11
VANN WALKE11
Fred Gruis11
Jay Farmer11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.